0001080368-24-000012.txt : 20240403 0001080368-24-000012.hdr.sgml : 20240403 20240403164412 ACCESSION NUMBER: 0001080368-24-000012 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240403 DATE AS OF CHANGE: 20240403 EFFECTIVENESS DATE: 20240403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RenaBio Therapeutics, Inc. CENTRAL INDEX KEY: 0002018021 ORGANIZATION NAME: IRS NUMBER: 931986428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-509574 FILM NUMBER: 24819583 BUSINESS ADDRESS: STREET 1: 22 STRATHMORE RD, #353 CITY: NATICK STATE: MA ZIP: 01760 BUSINESS PHONE: (617) 721-0785 MAIL ADDRESS: STREET 1: 22 STRATHMORE RD, #353 CITY: NATICK STATE: MA ZIP: 01760 D 1 primary_doc.xml X0708 D LIVE 0002018021 RenaBio Therapeutics, Inc. 22 STRATHMORE RD, #353 NATICK MA MASSACHUSETTS 01760 (617) 721-0785 DELAWARE None None Corporation true 2023 Ren Shengjun 22 STRATHMORE RD, #353 NATICK MA MASSACHUSETTS 01760 Executive Officer Director Jafari Mousa 22 STRATHMORE RD, #353 NATICK MA MASSACHUSETTS 01760 Director Other Health Care Decline to Disclose 06b false 2024-03-28 false true false 5000 4000000 1005000 2995000 false 18 0 0 0 false RenaBio Therapeutics, Inc. /Shengjun Ren/ Shengjun Ren Chief Executive Officer 2024-04-02